MAPS submits a Freedom of Information Act (FOIA) request to FDA seeking copies of all correspondence between FDA and either the DEA, the Office of National Drug Control Policy, or the Partnership for a Drug-Free America, regarding the MDMA/PTSD protocol. We’d like to see what, if anything, these organizations have been communicating to FDA regarding this study.